Myeloid Tumor Panel NGS Genetic DNA Test
Introduction to the Myeloid Tumor Panel NGS Genetic DNA Test
The Myeloid Tumor Panel NGS Genetic DNA Test is a state-of-the-art diagnostic tool that employs Next-Generation Sequencing (NGS) technology to identify genetic mutations associated with various myeloid tumors. This test plays a vital role in the early detection and management of cancers, allowing oncologists to develop personalized treatment strategies tailored to each patient’s unique genetic profile.
What the Test Measures
This genetic test analyzes specific genes commonly associated with myeloid malignancies, including mutations in genes such as ASXL1, ATM, CBL, CDKN2A, CEBPA, CREBBP, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, NF1, NOTCH1, NPM1, NRAS, PDGFRB, PHF6, PTPN11, RAD21, RUNX1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, and WT1. By identifying these mutations, healthcare providers can gain valuable insights into the prognosis and potential treatment options for patients.
Who Should Consider This Test
This test is particularly recommended for:
- Individuals exhibiting symptoms of myeloid tumors, such as unexplained fatigue, frequent infections, or easy bruising.
- Patients with a family history of myeloid malignancies or genetic predispositions to cancer.
- Those who have been diagnosed with myeloid tumors and require further genetic characterization for treatment planning.
Benefits of Taking the Test
Taking the Myeloid Tumor Panel NGS Genetic DNA Test offers numerous benefits:
- Accurate identification of genetic mutations, aiding in precise diagnosis.
- Personalized treatment plans based on individual genetic profiles.
- Enhanced understanding of cancer prognosis and potential treatment outcomes.
- Early detection of genetic predispositions, allowing for proactive health management.
Understanding Your Results
Upon receiving your test results, your healthcare provider will guide you through the findings. It is essential to understand that:
- Positive results may indicate the presence of mutations that could influence treatment options.
- Negative results do not completely rule out the presence of cancer but indicate no detected mutations in the analyzed genes.
- Your oncologist may recommend further testing or monitoring based on your results and overall health.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Myeloid Tumor Panel NGS Genetic DNA Test | 40,000 KSh | 60,000 KSh |
Book the Test Today!
We have branches across Kenya, including Nairobi, Mombasa, Kisumu, and more. For your convenience, we also offer home sample collection services. Don’t wait for symptoms to worsen; take charge of your health today! Call or WhatsApp us at +254119023975to book your Myeloid Tumor Panel NGS Genetic DNA Test.
Turnaround time: 3 to 4 weeks
Sample type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-test instructions: Clinical History of Patient who is going for Myeloid Tumor Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with relevant mutations.
